Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection [version 1; peer review: 2 approved]

• Published in: F1000 research Vol. 8; p. 1666
• Main Authors: Van Gerwen, Olivia T, Muzny, Christina A
• Format: Journal Article
• Language: English
• Published: England Faculty of 1000 Ltd 2019; F1000 Research Limited; F1000 Research Ltd
• Subjects: Clinical trials; Coinfection; Diagnosis; Epidemiology; Female; HIV; HIV Infections - complications; Human immunodeficiency virus; Humans; Infections; Male; Parasitic diseases; Patients; Pregnancy; Public health; Racial differences; Review; Sexually transmitted diseases; Sexually Transmitted Diseases - diagnosis; Sexually Transmitted Diseases - epidemiology; Sexually Transmitted Diseases - therapy; STD; Studies; Trichomonas Infections - diagnosis; Trichomonas Infections - epidemiology; Trichomonas Infections - therapy; Trichomonas vaginalis; United States; Womens health; United States; United States > US; South Africa; Trichomonas vaginalis; vaginal infections; STI
• ISSN: 2046-1402; 2046-1402
• DOI: 10.12688/f1000research.19972.1

Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection (STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the United States. Recent advances in the epidemiology, diagnosis, and management of T. vaginalis infection are described in this article. This includes updated global and U.S. prevalence data in women and men as well as recent epidemiological data in HIV-infected individuals and pregnant women. Advances in molecular diagnostics are also reviewed, as are data from recent clinical trials regarding the treatment of trichomonas in women.